A novel, quantitative bio-assay for cholecystokinin type-1 receptor activity in the anaesthetised rat

Journal of Pharmacological and Toxicological Methods

Volumn 54, Issue 1, 2006, Pages 36-41

  Freedman, Jamie M ^a   Barrett, Terrance D ^a   Shankley, Nigel P ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Agonist; Antagonist; CCK1; Cholecystokinin; Methods; Rat; Receptor

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; DEXLOXIGLUMIDE; GASTRAZOLE; LIGAND; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BALLOON; BIOASSAY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG INFUSION; DUODENUM; FREQUENCY ANALYSIS; INJECTION; INTESTINE CONTRACTION; INTESTINE PRESSURE; NONHUMAN; PRESSURE MEASUREMENT; PROTEIN DETERMINATION; PYLORUS; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SMOOTH MUSCLE CONTRACTILITY; SPHINCTER; TACHYPHYLAXIS;

ANESTHESIA; ANIMALS; BIOLOGICAL ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; SINCALIDE;

ANIMALIA;

EID: 33745646284     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2005.09.002     Document Type: Article

References (11)

1. Bignon E., Alonso R., Arnone M., Boigegrain R., Brodin R., Gueudet C., et al. SR146131: A new potent, orally active, and selective nonpeptide cholescystokinin subtype 1 receptor agonist: II. In vivo pharmacological characterization. Journal of Pharmacology and Experimental Therapeutics 289 (1999) 752-761
2. Latorre M., Bartolome-Nebreda J.M., Garcia-Lopez M.T., Gonzalez-Muniz R., Herranz R., Del Rio J., et al. Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis. Pharmacology 72 2 (2004) 68-76
3. Niederau M., Niederau C., Strohmeyer G., and Grendell J.H. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo. American Journal of Physiology 256 (1989) G150-G157
4. Roberts S., Griffin E.P., Harper E.A., Hull R.A.D., Kalinkjian B., Lilley E.J., et al. JB95008 (gastrazole), a selective CCK2 receptor (CCK2-R) antagonist with in vivo activity. Pharmacologist 44 2 (2002) A30.4 (Supp 1)
5. Scarpignato C., Kisfalvi I., D'Amato M., and Varga G. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: Evaluation of their receptor selectivity in vivo. Alimentary Pharmacology and Therapeutics 10 (1996) 411-419
6. Takashi S., Ukai K., Masuda T., Nakagawa T., Kimura K., Fujii M., et al. General pharmacological profile of the novel cholecystokinin-a antagonist loxiglumide. Arzneimittel-Forschung/Drug Research 47 II (1997) 1375-1382
7. Varga G., Balint A., Burghardt B., and D'Amato M. Involvement of endogenous CCK and CCK1 receptors in colonic motor function. British Journal of Pharmacology 141 8 (2004) 1275-1284
8. Varga G., Kisfalvi K., D'Amato M., and Scarpignato C. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat. Journal of Physiology (Paris) 91 3-5 (1997) 257-264
9. Varga G., and Scarpignato C. Camostate- and caerulein-induced delay of gastric emptying in the rat: Effect of CCK receptor antagonists. European Journal of Pharmacology 306 (1996) 153-159
10. Wank S.A. G protein-coupled receptors in gastro-intestinal physiology: I. CCK receptors: An exemplary family. American Journal of Physiology 274 (1998) G607-G613
11. White W., Schwartz G., and Moran T. Role of endogenous CCK in the inhibition of gastric emptying by peptone and intralipid in rats. Regulatory Peptides 88 (2000) 47-53